HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Treatment of postoperative gastrointestinal atony.

Abstract
One hundred and eighteen patients in whom postoperative gastrointestinal atony had lasted for 48-72 hours, were given one or two intravenous injections of different doses of cisapride (2, 4 or 8 mg), or vehicle. The first occurrence of flatus was taken to mark the cessation of ileus. There was no significant difference in remission of ileus between the groups in the first hour following injection. All patients not responding to treatment in the first hour were given a repeat dosage and observed for the following 3 hours. Among this group, there was a significant remission of ileus in patients who had received 2 X 8 mg, which was particularly marked in those who had undergone intraperitoneal surgery. This study suggests that cisapride in repeated dosage may be of value in inducing remission in prolonged surgical ileus, particularly in patients who have undergone intraperitoneal operations.
AuthorsM Verlinden, G Michiels, A Boghaert, M de Coster, P Dehertog
JournalThe British journal of surgery (Br J Surg) Vol. 74 Issue 7 Pg. 614-7 (Jul 1987) ISSN: 0007-1323 [Print] England
PMID3620873 (Publication Type: Journal Article)
Chemical References
  • Piperidines
  • Cisapride
Topics
  • Cisapride
  • Digestive System (physiopathology)
  • Dose-Response Relationship, Drug
  • Female
  • Gastrointestinal Diseases (drug therapy, physiopathology)
  • Gastrointestinal Motility (drug effects)
  • Humans
  • Intestinal Obstruction (drug therapy, physiopathology)
  • Male
  • Piperidines (adverse effects, therapeutic use)
  • Postoperative Complications (drug therapy, physiopathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: